Simplex Trading
TXMD icon

Simplex Trading’s TherapeuticsMD TXMD Stock Holding History

Simplex Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-428
Closed -$480 – 10116
2025
Q2 		$0 Buy
428
+195
+84% +$236 ﹤0.01% 9776
2025
Q1 		$0 Buy
233
+188
+418% +$187 ﹤0.01% 9728
2024
Q4 		$0 Buy
45
+43
+2,150% +$61 ﹤0.01% 9670
2024
Q3 		$0 Buy
+2
New +$3 ﹤0.01% 9628
2023
Q1 		– Sell
-1,118
Closed -$5.36K – 10175
2022
Q4 		$6K Buy
+1,118
New +$6.58K ﹤0.01% 7981
2021
Q2 		– Sell
-1,410
Closed -$85.4K – 10733
2021
Q1 		$0 Buy
+1,410
New +$110K ﹤0.01% 10072
2020
Q3 		– Sell
-217
Closed -$17.3K – 8548
2020
Q2 		$13K Buy
+217
New +$12.6K ﹤0.01% 6510
2019
Q4 		– Sell
-653
Closed -$93.9K – 8004
2019
Q3 		$118K Buy
+653
New +$92K ﹤0.01% 4138
2019
Q2 		– Sell
-982
Closed -$176K – 7818
2019
Q1 		$239K Buy
+982
New +$260K ﹤0.01% 3411
2018
Q4 		– Sell
-834
Closed -$203K – 7853
2018
Q3 		$273K Buy
834
+667
+399% +$204K ﹤0.01% 3291
2018
Q2 		$52K Sell
167
-166
-50% -$50.7K ﹤0.01% 5012
2018
Q1 		$80K Buy
+333
New +$93.4K ﹤0.01% 1987
2017
Q4 		– Sell
-172
Closed -$47.9K – 6717
2017
Q3 		$45K Sell
172
-601
-78% -$174K ﹤0.01% 2398
2017
Q2 		$203K Buy
773
+569
+279% +$143K 0.01% 1192
2017
Q1 		$73K Buy
204
+8
+4% +$2.48K ﹤0.01% 2019
2016
Q4 		$56K Buy
+196
New +$60.7K ﹤0.01% 2042
2015
Q4 		– Sell
-205
Closed -$75.7K – 6167
2015
Q3 		$60K Buy
205
+161
+366% +$57.2K ﹤0.01% 1841
2015
Q2 		$17K Buy
+44
New +$15.5K ﹤0.01% 2631

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TXMD Position: Q3 2025 in Review

Simplex Trading sold out of TherapeuticsMD (TXMD) in Q3 2025, closing a stake of 428 shares — an estimated $480 sold.

Simplex Trading first reported a position in TXMD in Q2 2015 and held it in 18 quarters. The position peaked at $273K in Q3 2018. 46 funds tracked by Wall St. Rank hold TXMD as of Q3 2025.

  • Simplex Trading reported no remaining TherapeuticsMD position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 428 TherapeuticsMD shares in Q3 2025, an estimated $480.
  • Simplex Trading first reported a position in TherapeuticsMD in Q2 2015 and held it in 18 quarters.
  • Simplex Trading's TherapeuticsMD position peaked at $273K in Q3 2018.
  • 46 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.